About Integumen
Integumen was a Healthcare company based in Dublin (Ireland) founded in 2017. It develops innovative technologies for skincare and wound dressing products. It operates on a B2B model. Integumen has completed 3 acquisitions, including Cellulac, Modern Water and RinoCloud. The company is recorded as dissolved. Its focus areas include Biotechnology, Skincare Products and Wound Dressing.
Company details
Integumen, established in 2017 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, skincare products, and wound dressing. Develops innovative technologies for skincare and wound dressing products. Adapting to market demands with innovation and client-focused strategies.
- Headquarters Dublin, Ireland
- Stage Public
- SectorsHealthcare
- Website integumen.com
- Social X Facebook
- Latest Funding Round$1.84M (USD), Post-IPO
Dec 2019
- Investments & AcquisitionsCellulac
& 2 more
Funding Insights of Integumen
- Total Rounds 1
- Last Round Post-IPO — $1.84M
- First Round $1.84M
(Dec 2019)
All 1 funding rounds of Integumen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2019 | $1.84M | Post-IPO | – | – | – |
Investments & Acquisitions by Integumen
Integumen has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cellulac, Modern Water and RinoCloud.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Membrane-based technologies are developed for wastewater treatment processes. | modernwater.com | Guildford, United Kingdom | 2006 | Aug 2020 | $28.12M | |
Enterprise data collaboration and research organization platform is provided. | rinocloud.com | Cambridge, United Kingdom | 2016 | Apr 2019 | $3.92M | |
Bioprocess technologies for biofuels and biochemicals are commercialized. | cellulac.com | London, United Kingdom | 2009 | Apr 2018 | •••• |
Complete acquisition details for Integumen
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Integumen
6 dated milestones of Integumen across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Integumen is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Cellulac.
- Acquisition Acquires RinoCloud.
- Funding First funding round of $1.8M.
- Acquisition Acquires Modern Water.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Integumen
Complete news archive for Integumen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Integumen
Integumen was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Integumen is headquartered in Dublin, Ireland.
Integumen, established in 2017 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, skincare products, and wound dressing. Develops innovative technologies for skincare and wound dressing products. Adapting to market demands with innovation and client-focused strategies.
Integumen has made 3 acquisitions, including Cellulac, Modern Water, and RinoCloud.